Trial intelligence / Profile preview

Local 5-fluorouracil injection for advanced gastric cancer

KCT0008395Phase 2Recruiting

Sponsor
Kangbuk Samsung Hospital
Start
May 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fluorouracil in gastric cancer (GC), sponsored by Kangbuk Samsung Hospital. Started May 2023; status: recruiting.

02

Drugs

fluorouracil
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on KCT0008395.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0008395.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call